Skip to main content

Table 2 Summary patient characteristics by metformin exposure status

From: Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

  Metformin exposed periods Metformin unexposed periods
(60,738.1 years) (66,165.9 years)
Age (Years) a 65.7 (57.3 - 73.5) 70.2 (61.1 – 78.1)
HbA1c % 7.3 (6.7- 8.3) 6.7 (6.2- 7.6)
(mmol/mol) a 56 (50 – 67) 50 (44 - 60)
Diabetes Duration (years) a 6.9 (3.7 – 11.2) 4.3 (1.8 – 8.9)
eGFR category (%)
>60 44,830.6 (73.8) 39,332.4 (59.4)
30-60 12,575.1 (20.7) 18,775.3 (28.3)
<30 ml/min/1.732 236.8 (0.4) 1592.7 (2.4)
ACE/ARB use (%) 25,572.6 (42) 21,827.7 (33)
NSAID use (%) 5967.4 (10) 6140.8 (9)
  1. aMedian & IQR